These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 2032232

  • 1. New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.
    Frühauf S, Zeller WJ.
    Cancer Res; 1991 Jun 01; 51(11):2943-8. PubMed ID: 2032232
    [Abstract] [Full Text] [Related]

  • 2. In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and -resistant rat ovarian tumors.
    Frühauf S, Zeller WJ.
    Cancer Chemother Pharmacol; 1991 Jun 01; 27(4):301-7. PubMed ID: 1998986
    [Abstract] [Full Text] [Related]

  • 3. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
    Bodenner DL, Dedon PC, Keng PC, Borch RF.
    Cancer Res; 1986 Jun 01; 46(6):2745-50. PubMed ID: 2870800
    [Abstract] [Full Text] [Related]

  • 4. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
    Chen G, Zeller WJ, Todorov DK.
    Anticancer Res; 1993 Jun 01; 13(5A):1269-75. PubMed ID: 8239496
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
    Murray D, Jenkins WT, Meyn RE.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6446-52. PubMed ID: 4063992
    [Abstract] [Full Text] [Related]

  • 6. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
    Chen G, Zeller WJ.
    Anticancer Res; 1991 Dec 01; 11(6):2231-7. PubMed ID: 1776864
    [Abstract] [Full Text] [Related]

  • 7. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
    Kelland LR, Mistry P, Abel G, Loh SY, O'Neill CF, Murrer BA, Harrap KR.
    Cancer Res; 1992 Jul 15; 52(14):3857-64. PubMed ID: 1617660
    [Abstract] [Full Text] [Related]

  • 8. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H, Drewinko B.
    Cancer Res; 1986 Mar 15; 46(3):1105-9. PubMed ID: 3080232
    [Abstract] [Full Text] [Related]

  • 9. Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity.
    Plooy AC, van Dijk M, Lohman PH.
    Cancer Res; 1984 May 15; 44(5):2043-51. PubMed ID: 6538808
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.
    Micetich KC, Barnes D, Erickson LC.
    Cancer Res; 1985 Sep 15; 45(9):4043-7. PubMed ID: 3896476
    [Abstract] [Full Text] [Related]

  • 11. Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin.
    Chen G, Zeller WJ.
    Anticancer Res; 1993 Sep 15; 13(1):219-23. PubMed ID: 8476216
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K.
    Biol Chem; 1999 Nov 15; 380(11):1287-94. PubMed ID: 10614821
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
    Swinnen LJ, Ellis NK, Erickson LC.
    Cancer Res; 1991 Apr 15; 51(8):1984-9. PubMed ID: 2009517
    [Abstract] [Full Text] [Related]

  • 14. The formation of DNA interstrand cross-links by a novel bis-[Pt2Cl4(diminazene aceturate)2]Cl4.4H2O complex inhibits the B to Z transition.
    González VM, Fuertes MA, Jiménez-Ruíz A, Alonso C, Pérez JM.
    Mol Pharmacol; 1999 Apr 15; 55(4):770-7. PubMed ID: 10101036
    [Abstract] [Full Text] [Related]

  • 15. Genotoxicity of novel trans-platinum(II) complex with diethyl (pyridin-4-ylmethyl)phosphate in human non-small cell lung cancer cells A549.
    Matlawska-Wasowska K, Rainczuk K, Kalinowska-Lis U, Osiecka R, Ochocki J.
    Chem Biol Interact; 2007 Jun 30; 168(2):135-42. PubMed ID: 17499650
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH, Steerenberg PA, Vos JG, Bulten EJ, Verbeek F, Kruizinga W, Ruitenberg EJ.
    Cancer Res; 1983 Oct 30; 43(10):4927-34. PubMed ID: 6683993
    [Abstract] [Full Text] [Related]

  • 17. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
    Ali-Osman F, Berger MS, Rajagopal S, Spence A, Livingston RB.
    Cancer Res; 1993 Dec 01; 53(23):5663-8. PubMed ID: 8242621
    [Abstract] [Full Text] [Related]

  • 18. Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes.
    Keppler BK, Schmähl D.
    Arzneimittelforschung; 1986 Dec 01; 36(12):1822-8. PubMed ID: 3566844
    [Abstract] [Full Text] [Related]

  • 19. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 20. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Sep 01; 54(17):4691-7. PubMed ID: 8062266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.